Sequence analysis of the VP4, VP6, VP7, and NSP4 gene products of the bovine rotavirus WC3

被引:15
作者
Ciarlet, M [1 ]
Hyser, JM [1 ]
Estes, MK [1 ]
机构
[1] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
关键词
rotavirus; vaccine; VP4; VP6; VP7; NSP4; WC3;
D O I
10.1023/A:1014512314545
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The bovine rotavirus (BRV) WC3 serves as the background strain in the development of a multivalent reassortant vaccine against rotavirus gastroenteritis in infants. The genes encoding the outer capsid spike protein VP4, the inner capsid protein VP6, the outer capsid glycoprotein VP7, and the viral enterotoxin NSP4 of BRV WC3 were sequenced. Comparative analysis of the deduced amino acids of the sequenced genes indicated that the BRV WC3 strain shares a high degree of amino acid identity with serotype P7[5] VP4 (93-96%), serotype G6 VP7 (91-97%), subgroup (SG) I VP6 (96-99%), and NSP4 genogroup A (96-98%) BRV strains. Our results confirm and extend previous studies which suggested that the VP4 of BRV WC3 was closely related to that of the P7[5] prototype, BRV UK. In addition, the VP6 and VP7 of BRV WC3 were very similar to the VP6 and VP7 of both SG I and G6 BRV NCDV and UK strains. However, the NSP4 of BRV WC3 was more closely related to that BRV NCDV, the P6[1] prototype, than to that of BRV UK.
引用
收藏
页码:107 / 118
页数:12
相关论文
共 67 条
[1]   Trypsin activation pathway of rotavirus infectivity [J].
Arias, CF ;
Romero, P ;
Alvarez, V ;
Lopez, S .
JOURNAL OF VIROLOGY, 1996, 70 (09) :5832-5839
[2]   Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein [J].
Ball, JM ;
Tian, P ;
Zeng, CQY ;
Morris, AP ;
Estes, MK .
SCIENCE, 1996, 272 (5258) :101-104
[3]  
BELL LM, 1987, P SOC EXP BIOL MED, V184, P127, DOI 10.3181/00379727-184-RC2
[4]   SEROLOGICAL CHARACTERIZATION OF BOVINE ROTAVIRUSES ISOLATED FROM DAIRY AND BEEF HERDS IN ARGENTINA [J].
BELLINZONI, RC ;
BLACKHALL, JO ;
MATTION, NM ;
ESTES, MK ;
SNODGRASS, DR ;
LATORRE, JL ;
SCODELLER, EA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (11) :2619-2623
[5]   Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial [J].
Bernstein, DI ;
Sack, DA ;
Rothstein, E ;
Reisinger, K ;
Smith, VE ;
O'Sullivan, D ;
Spriggs, DR ;
Ward, RL .
LANCET, 1999, 354 (9175) :287-290
[6]   Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12 [J].
Bernstein, DI ;
Smith, VE ;
Sherwood, JR ;
Schiff, GM ;
Sander, DS ;
DeFeudis, D ;
Spriggs, DR ;
Ward, RL .
VACCINE, 1998, 16 (04) :381-387
[7]   EVALUATION OF WC3 ROTAVIRUS VACCINE AND CORRELATES OF PROTECTION IN HEALTHY INFANTS [J].
BERNSTEIN, DI ;
SMITH, VE ;
SANDER, DS ;
PAX, KA ;
SCHIFF, GM ;
WARD, RL .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (05) :1055-1062
[8]   A BOVINE ROTAVIRUS SEROTYPE-1 - SEROLOGIC CHARACTERIZATION OF THE VIRUS AND NUCLEOTIDE-SEQUENCE DETERMINATION OF THE STRUCTURAL GLYCOPROTEIN VP7-GENE [J].
BLACKHALL, J ;
BELLINZONI, R ;
MATTION, N ;
ESTES, MK ;
LATORRE, JL ;
MAGNUSSON, G .
VIROLOGY, 1992, 189 (02) :833-837
[9]  
BRUSSOW H, 1994, J CLIN MICROBIOL, V32, P2876
[10]  
BRUSSOW H, 1992, J CLIN MICROBIOL, V30, P67